Medical Billing Company in Dubai — DHA & eClaimLink Specialists

Dubai operates under the Dubai Health Authority (DHA), separate from DoH (Abu Dhabi) and MoPH (Northern Emirates). Claims are submitted through eClaimLink, DHA's electronic claims platform, using DHA-specific rejection codes and payer rules. The regulatory posture, health-data policy (via the DHA data framework and NABIDH health information exchange) and inpatient reimbursement model all differ from Abu Dhabi and Sharjah. A billing operation built on DoH or MoPH assumptions does not transfer cleanly.

The core stack: DHA claim submission rules and eClaimLink formatting standards, DHA rejection-code taxonomy, DHA pricelists, DHA prior-authorisation requirements for specific procedure and drug categories, and NABIDH data-sharing requirements for participating facilities. Personal data across all of this is governed by UAE Federal Decree-Law No. 45 of 2021 on the Protection of Personal Data. Payers themselves (Daman, Nextcare, MetLife, and others) layer their own policy interpretations on top of DHA baseline rules.

eClaimLink is DHA's electronic claims submission and settlement platform — the mandatory channel through which DHA-licensed providers submit claims to Dubai payers. It defines the technical claim format (Post Office Protocol XML), the eligibility and pre-authorisation transactions, the settlement acknowledgement flow and the rejection response codes. Everything about a Dubai billing operation — from patient registration to denial workflow — has to be built around eClaimLink's transaction model, not adapted from a different platform.

Yes, since 2020. DHA introduced IR-DRG (International Refined Diagnosis-Related Groups) for inpatient reimbursement in 2020, following Abu Dhabi's 2010 adoption. Under IR-DRG, hospital reimbursement per inpatient episode is determined by the DRG classification, which is driven by the ICD-10-AM codes and clinical documentation. Errors in ICD-10-AM coding cause DRG misclassification, which translates directly into revenue loss or audit exposure. Dubai hospitals need strong ICD-10-AM coding and CDI (clinical documentation improvement) capability, not just outpatient claim scrubbing.

Baseline denial rates in Dubai cluster around 8–15% for smaller clinics on generic billing setups and 4–8% for hospitals with dedicated coding teams. A well-run RCM engagement typically pushes first-pass denial rates below 5%, with structured appeal recovering another 40–70% of denials that do occur. Specialty mix matters — high-cost, high-touch specialties (oncology, cardiology, orthopaedics) tend to see higher baseline denials and higher recoverable revenue when the process is tightened.

Yes. Multi-emirate providers are common, and Truescience handles DHA (Dubai), DoH (Abu Dhabi) and MoPH (Sharjah, Northern Emirates) claims under a single coordinated engagement — not three separate vendor relationships. Each facility runs against its own regulatory ruleset. Cross-emirate providers get consolidated KPI reporting rather than fragmented per-emirate views.

DHA-licensed hospitals, specialist clinics, day-surgery centres, diagnostic laboratories, pharmacies, medical centres and dental practices. Engagement structure — remote, on-site or hybrid — is scoped per client based on claim volume, specialty mix and existing internal capability.

Two things. First, we work natively across all three UAE regulators (DoH, DHA, MoPH) rather than DHA only — so multi-emirate providers get one relationship, not three. Second, our operating pattern is regulator-specific: DHA claims are worked with an eClaimLink-native workflow calibrated to Dubai payer rules, not a generic UAE billing process. For hospitals, ICD-10-AM coding is done with IR-DRG accuracy as the target, not as an afterthought.